PHA-793887 2 mg | 100.00%
TargetMol
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
More Information Supplier PagePHA-793887
Search Results
Bikinin 25 mg | 99.91%
TargetMol
Bikinin, a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor.
More Information Supplier PageBikinin
Bikinin 50 mg | 99.91%
TargetMol
Bikinin, a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor.
More Information Supplier PageBikinin
CTX-0294885 10 mg | 99.95%
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information Supplier PageCTX-0294885
CTX-0294885 50 mg | 99.95%
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information Supplier PageCTX-0294885
CTX-0294885 5 mg | 99.95%
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information Supplier PageCTX-0294885
Mutant IDH1-IN-1 10 mg | 98.98%
TargetMol
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM.
More Information Supplier PageMutant IDH1-IN-1
Mutant IDH1-IN-1 2 mg | 98.98%
TargetMol
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM.
More Information Supplier PageMutant IDH1-IN-1
Mutant IDH1-IN-1 5 mg | 98.98%
TargetMol
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM.
More Information Supplier PageMutant IDH1-IN-1
Raf inhibitor 1 10 mg | 98.05%
TargetMol
Raf inhibitor 1
